Filing Flows › Omnicell (OMCL) › R&D spending
Omnicell (OMCL) R&D spending by quarter
Omnicell's R&D spending was $22.4M in Q3 2026 (third quarter 2026), +10% from Q2 2026. Over the last 7 quarters it ranged from $20.3M (Q2 2026) to $24.0M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $22.4M | +10% | -7% |
| Q2 2026 | $20.3M | -6% | -6% |
| Q1 2026 | $21.5M | -5% | +5% |
| Q4 2025 | $22.6M | -6% | — |
| Q3 2025 | $24.0M | +11% | — |
| Q2 2025 | $21.6M | +5% | — |
| Q1 2025 | $20.5M | — | — |
Q3 2026 at a glance
Omnicell, Q3 2026: revenue $308M (-0.9% year over year), operating margin 4.9%, net earnings $11.0M, operating cash flow $33.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Omnicell's R&D spending?
Omnicell's R&D spending was $22.4M in Q3 2026 (third quarter 2026), +10% from Q2 2026.
How has Omnicell's R&D spending changed?
Over the last 7 quarters it ranged from $20.3M (Q2 2026) to $24.0M (Q3 2025).